Johnson & Johnson (JNJ) vs Mastercard Incorporated (MA)

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.

Mastercard Incorporated is the world’s second-largest payment processor, handling nearly $11 trillion in payment volume during 2025. The company operates in more than 200 countries and territories and processes transactions in over 150 currencies worldwide.